WHO recommends the use of interleukin-6 receptor antagonists to treat new coronary pneumonia
Home> News> eCompany
WHO recommends the use of interleukin-6 receptor antagonists to treat new coronary pneumonia
2021-07-07 06:22
Source: Securities Times
Securities Times
2021-07-07 06:22
Securities Times e company reported that on July 6, local time, the WHO updated the guidelines for the care of patients with new coronary pneumonia to include interleukin-6 receptor antagonists. The WHO claims that the drug can save the lives of severe and critically ill patients with new coronary pneumonia, and is particularly effective when used with corticosteroids. Studies have shown that compared with standard treatment, the use of the drug in severe or critically ill patients can reduce the chance of death by 13%. (CCTV News)
Disclaimer: The Securities Times strives for truthful and accurate information. The content mentioned in the article is for reference only and does not constitute substantive investment advice. The operation is at your own risk.
3412499
WHO recommends the use of interleukin-6 receptor antagonists to treat new coronary pneumonia
6885
e company
news
1429
2021-07-07